State Street Corp Xenetic Biosciences, Inc. Transaction History

State Street Corp

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 16, 2022	BUY	$0.88 - $1.37 $675 - $1,052	768 Added 2.27%	34,668 $35,000
Q3 2021 Nov 15, 2021	BUY	$1.73 - $5.3 $58,647 - $179,670	33,900 New	33,900 $69,000

Ticker XBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,166,600
Market Cap $64.6M
Description
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the discovery, research, and development of biologic drugs and oncology therapeutics. It advances cell-base...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.